Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0376358 (prostate cancer)
 59,338 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We assessed the usefulness of endorectal surface coil MRI (ERSC-MRI) for staging diagnosis of prostate cancer to compare preoperative ERSC-MRI findings with pathological staging in patients performed radical prostatectomy. MR imaging was performed on a 1.5 T MR system with an endorectal surface coil designed for imaging the prostate. At the time the coil was inserted, 1.0 mg of glucagon was injected in tramuscularly. T1-weighted MR images were obtained in the axial plane, and T2-weighted, spin echo MR images were obtained in the sagittal, coronal, and axial planes for each patient. The capsular penetration of prostatic cancer was defined according to the six diagnostic criteria by Outwater et al.: (1) a bulge formation of the low-signal-intensity area beyond the prostatic capsule, (2) low-signal-intensity stranding in the periprostatic tissue, (3) retraction of the prostatic capsule besides the low-signal-intensity area, (4) elongation of the low-signal-intensity area in the prostatic capsule, (5) thickening of prostatic capsule. (6) extracapsular tumor. The sensitivity, specificity and accuracy of ERSC-MRI for capsular penetration of the prostatic cancer were 95.5%, 40.0%, and 85.2%, respectively. These results indicate that ERSC-MRI is useful for staging diagnosis of prostatic cancer.
 ...
PMID:[Assessment of local staging of prostate cancer by endorectal surface coil]. 975 May 5

A 62 element MRI-compatible linear phased array was designed and constructed to investigate the feasibility of using transrectal ultrasound for the thermal therapeutic treatment of prostate cancer and benign prostatic hyperplasia. An aperiodic design technique developed in a previous study was used in the design of this array, which resulted in reduced grating lobe levels by using an optimized random distribution of unequally sized elements. The element sizes used in this array were selected to be favorable for both grating lobe levels as determined by array aperiodicity and array efficiency as determined by width to thickness ratios. The heating capabilities and MRI compatibility of the array were tested with in vivo rabbit thigh muscle heating experiments using MRI temperature monitoring. The array produced therapeutic temperature elevations in vivo at depths of 3-6 cm and axial locations up to 3 cm off the central axis and increased the size of the heated volume with electronic scanning of a single focus. The ability of this array to be used for ultrasound surgery was demonstrated by creating necrosed tissue lesions in vivo using short high-power sonications. The ability of the array to be used for hyperthermia was demonstrated by inducing therapeutic temperature elevations for longer exposures. Based on the acoustic and heating performance of this array, it has the potential to be clinically useful for delivering thermal therapies to the prostate and other target volumes close to body cavities.
 ...
PMID:Intracavitary ultrasound phased arrays for prostate thermal therapies: MRI compatibility and in vivo testing. 987 33

The purpose of this study was to evaluate the ability of MR imaging with an endorectal coil (erMRI) to predict the local pathological stage of prostatic carcinoma prior to radical prostatectomy. Thirty-one consecutive patients (median age 61 years, range 40-71 years) with clinically localised prostate cancer were assessed preoperatively by endorectal MRI (at 1.0 T). The pulse sequences consisted of fast spin-echo axial and coronal T2-weighted images and inversion recovery with two echoes for axial fat-suppressed images. The assessment of tumour stage and measurement of tumour dimension by erMRI were compared with the corresponding findings on whole-mount step sections of the surgical specimens. Postoperatively, 14 of the 31 patients (45 %) were found to have extracapsular extension, 7 with capsular penetration (CP) only, and 7 had a combination of CP and seminal vesicle invasion (SVI). Capsular penetration was detected by erMRI with a sensitivity of 0.71 and specificity of 0.47, whereas the sensitivity for SVI detection was 0.71 and the specificity 0.83. Endorectal MRI for staging clinically localised prostatic carcinoma gives a good prediction of invasion of the seminal vesicles but is unreliable in predicting capsular penetration.
 ...
PMID:MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. 993 75

Two cases of spinal epidural lipomatosis (SEL) were reported. Patient 1 was on oral corticosteroid and patient 2 was obese and had prostate cancer. Patient 1 was a 45-year-old man diagnosed as sarcoid myelopathy at C 5/6 vertebral body levels and had been placed on oral corticosteroid therapy for 14 months. He showed spastic paraplegia, hypesthesia below C 4 level with distal dominancy and dysesthesia below Th 6 level. MRI revealed epidural lipomatosis from Th 3 to Th 9 vertebral bodies, which presented high in T 1 weighted image (WI) and T 2 WI, and non-signal in STIR image. On axial image spinal cord was compressed by this mass. Patient 2 was a 73-year-old man with spastic paraplegia, and superficial and deep sensory disturbances below Th 6. He had been obese (BMI 26.1) upon admission. He was diagnosed as prostate cancer with bone metastasis. On MRI of the thoracic spine revealed epidural mass of high in T 1 WI and T 2 WI, and non-signal in STIR image. SEL is a rare condition known as hyperplasia of normal fat tissue in epidural space which sometimes compresses the spinal cord or spinal nerve roots resulting in neurologic deficit. SEL should be kept in mind as having possible neurologic complications in obese patients or ones on long term steroid therapy.
 ...
PMID:[Two cases of spinal epidural lipomatosis]. 1050 88

This feasibility study was performed to evaluate the suitability of MRI in defining appropriate pelvic radiotherapy treatment volumes, and to compare MRI sequences with CT for prostate cancer radiotherapy. Five patients with localized prostate cancer, imaged with four MRI sequences (spin echo (SE) T1, turbo SE (TSE) T2, high resolution TSE (HR) T2, and FLASH 3D (F3D)), compared with their corresponding CT planning scans. Segmentation ability of the following pelvic structures: prostatic apex (PA), prostate, rectum, bladder and seminal vesicles (SV), were evaluated by three independent observers. They used a five point grading scale based on the anatomical definition of the organ boundary, tissue contrast and multiplanar display. Results were averaged for the group and for each sequence. There was no significant interobserver variation in the assessed scores (p > 0.1). The average scores (+/- 1 SD) for all pelvic structures assessed by each imaging sequence were CT 1.3 +/- 0.6; SE T1 2.4 +/- 0.9; TSE T2 2.4 +/- 0.7; HR T2 2.2 +/- 0.7 and F3D 3.4 +/- 0.6. Compared with CT, the average MR score for each assessed pelvic structure was higher with a trend for all transaxial MR sequences to provide improved segmentation of the PA and rectum. The F3D sequence scored highest as it provided multiplanar views and avoided the problem of partial volume averaging. MRI, compared with CT, appears to provide improved definition of pelvic treatment volumes but further work is required to confirm this and to address the issues of MRI associated distortion and dosimetry before MRI can be used routinely for pelvic radiotherapy planning.
 ...
PMID:Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. 1056 Mar 42

MRI with an endorectal coil gives images of the prostate gland and seminal vesicles of higher quality than any other imaging modality. The use of an endorectal coil enables us to sample stronger radiofrequency signals from the prostate gland and seminal vesicles compared to a whole-body coil. This improves the contrast resolution in MR images and may give a higher spatial resolution by use of thin slices and a smaller slice gap. Intravenous MRI contrast is not used in our standard procedure. At Haukeland University Hospital, Norway, MRI with an endorectal coil is presently used as a tool for solving special problems in relation to detection and staging of prostate cancer, for example in patients with an abnormal s-PSA and negative sextant biopsies from the prostate gland. Furthermore, MRI with an endorectal coil may be used for the diagnosis of some benign diseases. The specific role of MRI with an endorectal coil in clinical use is not clarified; further research is needed. This article gives a short overview of technical aspects, imaging protocols, image reading, indications and diagnostic criteria for some diseases.
 ...
PMID:[Magnetic resonance tomography with endorectal coil for examination of prostate and seminal vesicles]. 1080 82

Clinical applications of magnetic resonance spectroscopic imaging (MRSI) for the study of brain and prostate cancer have expanded significantly over the past 10 years. Proton MRSI studies of the brain and prostate have demonstrated the feasibility of noninvasively assessing human cancers based on metabolite levels before and after therapy in a clinically reasonable amount of time. MRSI provides a unique biochemical "window" to study cellular metabolism noninvasively. MRSI studies have demonstrated dramatic spectral differences between normal brain tissue (low choline and high N-acetyl aspartate, NAA) and prostate (low choline and high citrate) compared to brain (low NAA, high choline) and prostate (low citrate, high choline) tumors. The presence of edema and necrosis in both the prostate and brain was reflected by a reduction of the intensity of all resonances due to reduced cell density. MRSI was able to discriminate necrosis (absence of all metabolites, except lipids and lactate) from viable normal tissue and cancer following therapy. The results of current MRSI studies also provide evidence that the magnitude of metabolic changes in regions of cancer before therapy as well as the magnitude and time course of metabolic changes after therapy can improve our understanding of cancer aggressiveness and mechanisms of therapeutic response. Clinically, combined MRI/MRSI has already demonstrated the potential for improved diagnosis, staging and treatment planning of brain and prostate cancer. Additionally, studies are under way to determine the accuracy of anatomic and metabolic parameters in providing an objective quantitative basis for assessing disease progression and response to therapy.
 ...
PMID:Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. 1093 75

The incidence of prostate disease is high. However, accurate assessment of pathological conditions is still difficult. Although CT, MRI, and TRUS imaging methods provide useful information, each has specific drawbacks. Our work examines the potential and utility of 3D trans-urethral ultrasound (TUUS) for improved imaging of the prostate. Four normal canines were examined with TUUS. The catheter was placed in the urethra and used to image the prostate, rectum, bladder, ureter, neuro-vascular bundles, arteries, and surrounding tissue. 2D and 3D datasets were acquired and digitized. The 2D data provides useful visualization of the tissue. The clinician was also able to watch urine enter the bladder and perform a digital rectal exam in real-time. 3D data visualization required torodial reconstruction. The algorithm was optimized to provide very fast 3D reconstructions of the prostate. Segmentation of the data proved challenging, but 3D visualization, including volume rendered data and surface rendered data, were well accepted by clinicians. Clinicians and researchers determined a number of potential applications of these new techniques, including: prostate cancer diagnosis and staging, assessment of Benign Nodular Enlargement, assessment of physiologic function of the bladder, evaluation of morphologic properties of the prostate, and image guided biopsy and therapy.
 ...
PMID:Trans-urethral ultrasound (TUUS) imaging for visualization and analysis of the prostate and associated tissues. 1097 25

Over the past decade, numerous minimally invasive thermal procedures have been investigated to treat benign prostate hyperplasia and prostate cancer. Of these methods, ultrasound has shown considerable promise due to its ability to produce more precise and deeper thermal foci. In this study, a linear, transrectal ultrasound phased array capable of ablating large tissue volumes was fabricated and evaluated. The device was designed to be compatible for use with MRI guidance and thermometry. The intracavitary applicator increases treatable tissue volume by using an ultrasonic motor to provide a mechanical rotation angle of up to 100 degrees to a 62-element 1D ultrasound array. An aperiodic array geometry was used to reduce grating lobes. In addition, a specially designed Kapton interconnect was used to reduce cable crosstalk and hence also improve the acoustic efficiency of the array. MRI-guided in vivo and ex vivo experiments were performed to verify the array's large-volume ablative capabilities. Ex vivo bovine experiments were performed to assess the focusing range of the applicator. The array generated foci in a 3 cm (2 to 5 cm from the array surface along the axis normal to the array) by 5.5 cm (along the long axis of the array) by 6 cm (along the transverse axis of the array at a depth of 4 cm) volume. In vivo rabbit thigh experiments were performed to evaluate the lesion producing capabilities in perfused tissue. The array generated 3 cm x 2 cm x 2 cm lesions with 8 to 12 half-minute sonications equally spaced in the volume. The results indicate that transrectal ultrasound coagulation of the whole prostate is feasible with the developed device.
 ...
PMID:The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array. 1109 11

The role of magnetic resonance (MR) imaging and MR spectroscopy with an endorectal coil in tissue characterization and local staging was reviewed. Endorectal coil (ERC) MR imaging demonstrated the detailed zonal anatomy of the normal prostate. The sensitivity and specificity of staging prostate cancer for ERC MR imaging was superior to both conventional MR imaging and transrectal ultrasound. ERC MR imaging is the most accurate noninvasive method of staging prostate cancer. However, the accuracy of the diagnosis made by inexperienced radiologists was significantly inferior to that made by experienced radiologists. Endorectal MRI failed to differentiate benign from malignant lesions in some patients demonstrating low signal intensity on T2-weighted imaging in the peripheral zone. MR spectroscopy may provide additional information on tissue characterization, monitoring after treatment and staging.
 ...
PMID:[Staging and tissue characterization of prostate carcinoma: role of endorectal MR imaging and MR spectroscopy]. 1119 12


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>